Bronislaw Pytowski

Biochemistry, Genetics and Molecular Biology · Life Sciences

42h-index9.1kcitations100works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Angiogenesis and VEGF in Cancer(42), Lymphatic System and Diseases(39), Vascular Tumors and Angiosarcomas(11), Sympathectomy and Hyperhidrosis Treatments(10), Vascular Malformations and Hemangiomas(8)

Publications100 total

Correction: Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human antihuman VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C
Journal of Cell Science·2023Open Access
Xerna™ TME Panel is a machine learning-based transcriptomic biomarker designed to predict therapeutic response in multiple cancers
Frontiers in Oncology·2023· 7 citedOpen Access
Supplemental Figures from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Supplemental Figures from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Data from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Data from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Supplemental Figures 1 through 9 and Supplemental Tables 1 and 2 from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Supplemental Figures 1 through 9 and Supplemental Tables 1 and 2 from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Supplemental Methods from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Supplemental Figure Legends from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Supplemental Methods from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Supplemental Figure Legends from Stromal-Based Signatures for the Classification of Gastric Cancer
2023Open Access
Data from Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth
2023Open Access
Supplementary Figure 1 from Suppression of Prostate Cancer Nodal and Systemic Metastasis by Blockade of the Lymphangiogenic Axis
2023Open Access
Data from Suppression of Prostate Cancer Nodal and Systemic Metastasis by Blockade of the Lymphangiogenic Axis
2023Open Access
Supplementary Table 1 from Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth
2023Open Access
Supplementary Table 1 from Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth
2023Open Access
Supplementary Figure 1 from Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth
2023Open Access
Supplementary Figure 1 from Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth
2023Open Access
Supplementary Figure 1 from Suppression of Prostate Cancer Nodal and Systemic Metastasis by Blockade of the Lymphangiogenic Axis
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Kari Alitalo(14), Daniel J. Hicklin(11), Zhenping Zhu(8), Yan Wu(8), Larry Witte(7), Kris Persaud(7), Seppo Ylä‐Herttuala(6), Peter Böhlen(6), Claus Cursiefen(5), Tuomas Tammela(4), J. Wayne Streilein(4), Jeremy Goldman(4), Pirjo Laakkonen(3), Andrea T. Hooper(3), Luc de Witte(3), Peter Bałuk(3), Marc G. Achen(3), Tatiana V. Petrova(3), Steven A. Stacker(3), David G. Jackson(3)